Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New mouth pad aims to heal radiation sores faster

NCT ID NCT06276270

Symptom relief Sponsor: Contipro Pharma a.s. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new device called Mucopad HA in 50 adults who had painful mouth sores (oral mucositis) after radiation therapy. The goal was to see if the pad is safe and helps the sores heal. Researchers measured healing time, pain levels, and dry mouth.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

50 people

The number who actually took part.

Started

Dec 2023

Finished

Nov 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 18 years * Oral Mucositis after radiotherapy of grade I - IV according to WHO * Patient willing and able to provide the written consent * Ability to communicate well with the investigator in the local language, and to understand and comply with the requirements of the study Exclusion Criteria: * Age \< 18 years * Pregnant or lactating women * Patients in terminal stage of living * Patients with known hypersensitivity or allergy to any of the substances contained in Medical Device * Alcohol or drug abuse

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Oral mucositis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

stomatitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Oral mucositis

Contacts and locations

Locations

  • Etická komise FN Bulovka

    Prague, Česká Republika, 56401, Czechia

  • FN Hradec Králové Klinika onkologie a radioterapie

    Hradec Králové, Česká Republika, 56401, Czechia

  • Fakultní Thomayerova nemocnice Onkologická klinika 1.LF UK a FTN

    Prague, Česká Republika, 56401, Czechia

  • Fakultní nemocnice Ostrava, Klinika onkologická

    Ostrava, Česká Republika, 56401, Czechia

  • Masarykův onkologický ústav, Klinika radiační onkologie

    Brno, Česká Republika, 56401, Czechia

More trials for these conditions

Other studies related to the condition(s) this trial covers.